Vaxcyte Income from Continuous Operations 2019-2024 | PCVX
Vaxcyte income from continuous operations for the twelve months ending December 31, 2024 was $-0.464B, a 15.33% increase year-over-year.
- Vaxcyte annual income from continuous operations for 2024 was $-0.464B, a 15.33% increase from 2023.
- Vaxcyte annual income from continuous operations for 2023 was $-0.402B, a 80% increase from 2022.
- Vaxcyte annual income from continuous operations for 2022 was $-0.223B, a 123.31% increase from 2021.